Macclesfield, in the north-west of England, is our second largest manufacturing site and our European centre for packing.
Some 1,800 people are employed at our Macclesfield site, where we manufacture, pack and distribute our medicines to 130 global markets.
Effective manufacturing processes are vitally important to our work, so we’ve introduced new techniques at Macclesfield which have increased efficiency significantly.
The production line at Macclesfield for Zoladex, used to treat hormone-sensitive cancers of the prostate and breast, is the only one of its kind globally, requiring a complex aseptic technique to ensure the sterility of the drug. In November 2013, we announced investment of £120 million in a new facility for Zoladex. This secured 300 existing jobs at the site and is expected to create over 200 temporary jobs between now and early 2017. This investment is a further signal of our long term commitment to the UK and to the North West.